What the Transcriptome of the Eutopic Endometrium from Women with Endometriosis tells us about the Disease Pathophysiology: A Brief Reflection

Editorial What the Transcriptome of the Eutopic Endometrium from Women with Endometriosis tells us about the Disease Pathophysiology: A Brief Re flection Omero Benedicto Poli-Neto 1 Juliana Meola 1 Julio Cesar Rosa-e-Silva 1 1 Department of Gynecology and Obstetrics, Division of Gynecological Surgery, Faculty of Medicine, Universidade de S ã oP a u l o ,R i b e i r ã oP r e t o ,S P ,B r a z i l Rev Bras Ginecol Obstet 2020;42(10):593 –596. Endometriosis is characterized by the presence of endometrial- like tissue outside the uterine cavity, usually represented by deep peritoneal, ovarian and/or infiltrative lesions1,2 and, more rarely, in extrapelvic sites.3 The estimated prevalence is of 5 to 10% of reproductive-age women,4–6 despite the suggestion of an actual lower prevalence, of up to 1.8%, in a recently published study based on a population of two million individ- uals. 7 The incidence, in turn, is more dif ficult to be estimated, but seems to be between 1.3 to 1.6 cases per 1,000 women in this same age group. 8 Even considering this wide variation, if extrapolating to the Brazilian female population aged between 15 and 50 years estimated in the last census of 2010, there may be between 1 million and more than 5 million women with endometriosis, which is a very expressive number. Women with endometriosis may be asymptomatic or have varied symptoms, with the most frequent being pain (dysmenorrhea, dyskinesia, acyclic pain, dyspareunia) and infertility, followed by abnormal uterine bleeding and ovarian mass. 9,10 Despite these associations, there are no clinical symptoms or signs that are good predictors of the disease,11,12 which culminates in the difficulty of an accurate clinical diagnosis. 13 Other important aspects are the absence of a correlation between the severity of symptoms and extent of the disease, 14 the presence of endo- metriosis in a reasonable number of asymptomatic women,15 and the lack of knowledge about the events determining the natural evolution of the disease, be it spontaneous progression or regression. 16 Nonetheless, the disease is associated with a significant psychological and social impact, negative repercus- sions on the woman’s quality of life17 and productivity,18 and relevant socioeconomic burden.19,20 Several theories have been proposed to explain the origin of the disease, among which are theories of retrograde menstru- ation (the most widespread and accepted), celomic metaplasia, lymphovascular metastasis, and, more recently, the theory of neonatal uterine bleeding. 21,22 Although reasonable, by them- selves these theories do not explain the origin and evolution of the disease in all its nuances, and other factors need to be considered, such as: genetic, endocrine, immunological, inflammatory, and neuroangiogenic. Regardless of controver- sies, the eutopic endometrium in women with the disease definitely has peculiarities and a relevant role in the patho- physiological process of the disease. 23–25 If we added genetic susceptibility26 and immune system dysfunction to this con- text, including autoimmunity and de ficient immune surveil- lance,27–29 we would already have a plausible explanation for the question of why only some women develop the disease. Still, there would be another question: what would be or what would lead to this initial alteration of the eutopic endometri- um? A potential explanation would be the presence of somatic mutations in the epithelial and/or stromal endometrial com- ponents. Despite their relevance to ovarian lesions (endome- triomas), they do not appear to be crucial or signi ficant in components of the eutopic endometrium. 30 Another interest- ing element is the importance of endometrial progenitor cells, or endometrial stem cells in their broadest concept. However, although admittedly associated with the development of the lesion at ectopic sites, 31 primary constitutive changes in these cells, when isolated from the eutopic endometrium, are still controversial. In this scenario of uncertainties about the triggering event of the first changes in the eutopic endo- metrium of women with endometriosis, it is worth discussing an equally interesting, although less explored, hypothesis of microbiological contamination. Some authors defend intra- uterine microbial colonization as the trigger for pathophysio- logical events that culminate in endometriosis. 32 Furthermore, infections can trigger cumulative genetic and epigenetic changes with the potential to trigger or maintain endometri- osis. 33 Although recently published, the concept of an initial eutopic endometrial infection followed by sterile in flamma- tion has been proposed before. 34 These propositions are Address for correspondence Omero Benedicto Poli-Neto, MD, PhD, Faculdade de Medicina, Universidade de São Paulo, Av. Bandeirantes, 3900, Vila Monte Alegre, Ribeirão Preto, SP, 14049- 900, Brazil (e-mail: [email protected]). DOI https://doi.org/ 10.1055/s-0040-1713807. ISSN 0100-7203. Copyright © 2020 by Thieme Revinter Publicações Ltda, Rio de Janeiro, Brazil THIEME Editorial 593 Article published online: 2020-10-31 supported by the association between endometriosis and endometritis, 13,35–39 by the microbial contamination observed in the uterine cavity and ectopic lesions, 40–42 and by dysbiosis in the microbiome of the intestine and genital tract of women with endometriosis. 43 Concomitant to these findings, the modernization of molecular biology techniques in recent decades has allowed great advances in understanding the processes involved in the evolution of several diseases. Currently, these methodol- ogies are more affordable, easy to execute, and have good reproducibility. 44,45 Transcriptome analysis, for example, is a direct re flection of gene expression in tissues. In this sense, the transcriptome analysis of the eutopic endometrium of women with endometriosis has an invaluable potential in contributing to understand local events associated with the condition. In fact, there are already relevant studies evaluat- ing the transcriptome of the eutopic endometrium of women with and without endometriosis. 46–50 However, some limi- tations are inherent to these studies, such as: reduced casuistry size; heterogeneous sample regarding phenotypic characterization, mainly of the menstrual cycle phase, the extent of the lesions, and associated symptoms; inadequate selection of healthy controls; non-optimized evaluation by the bioinformatics tools available; and redundancy in the interpretation of biological pathways, among others. To try to remedy these limitations, our group conducted a meta-analysis including raw eutopic endometrial transcrip- tome data available in international databases from healthy women and from women with endometriosis. We restricted the control group to women with no known disease and stratified women with endometriosis into those with stages I and II disease and those with stages III and IV disease. For both groups, we considered the phase of the menstrual cycle, since it can interfere with the expression of the tissue tran- scriptome. 51 By using some bioinformatics tools, we were able to predict the tissue microenvironment computational- ly, that is, we could infer the types of cells present in each sample. The method used can identify 64 cell types, including immune cells, stem cells, and stromal cells, among others. Thus, we observed that the eutopic endometrium of women with endometriosis in stages I and II has more proin flam- matory characteristics than the endometrium of women in stages III and IV of the disease. Initial cases have a predominance of activated dendritic cells, effector memory CD4þ T-cells, eosinophils, type M1 macrophages and natural killer T-cells, which are typical of an in flammatory process induced by acute infections. In more advanced cases (stages III and IV), there is a predominance of M2 macrophages and natural killer T-cells. This last cell pro file is characteristic of an antiin flammatory process, of tissue healing and repair 52 present in late stages of infectious diseases 53 that may be associated with the promotion of tumor growth. 54 As for biological pathways, in women with endometriosis there is a direct involvement of the processes related to immune surveillance, stem cell self-renewal, and epithelium-mesen- chymal transition. These mechanisms are already reported in the literature, but we note that pathways related to greater permissiveness of the immune system to cells in ectopic environments and imbalance between cell growth and sur- vival 55 are more evident in advanced disease. Anyway, the predominance of different cell types added to the interaction between genes and the predominant biological pathways in each condition, regardless of the phase of the menstrual cycle, indicates that the eutopic endometrium of women affected by endometriosis has peculiar characteristics of a tissue that suffered or has been suffering some harm, ag- gression, or stress caused by an external, potentially micro- biological agent. Based on what was brie fly mentioned above, thinking about an initial endometrial aggression, possibly by a micro- biological agent, sustained for a variable period of time, and followed by the induction of genetic and epigenetic changes in the tissue and consequent self-sustained in flammation (sterile or not), all occurring in a genetically susceptible woman, whose immune system behaves anomalously and is permissive to the presence of endometrial cells (especially stem cells) in ectopic environments, would be an at least plausible hypothesis and justify further investigations. How- ever, studies must be conducted to resolve limitations that may skew the results obtained, especially a good phenotypic characterization of patients and a good selection of healthy controls. Conflict of Interests The authors have no con flict of interests to declare. Acknowledgments We thank the Coordination for the Improvement of Higher Education Personnel (CAPES in the Portuguese acronym) for the support to our postgraduate program. References 1 Agarwal N, Subramanian A. Endometriosis - morphology, clinical presentations and molecular pathology. J Lab Physicians. 2010;2 (01):1–9. Doi: 10.4103/0974-2727.66699 2 Nisolle M, Donnez J. Reprint of: Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril. 2019;112(04, Suppl 1):e125 –e136. Doi: 10.1016/j.fertnstert.2019.08.081 3 Andres MP , Arcoverde FVL, Souza CCC, Fernandes LFC, Abrão MS, Kho RM. Extrapelvic endometriosis: a systematic review. J Minim Invasive Gynecol. 2020;27(02):373–389. Doi: 10.1016/j.jmig.2019.10.004 4 Cramer DW, Missmer SA. The epidemiology of endometriosis. Ann N Y Acad Sci. 2002;955(01):11 –22, discussion 34 –36, 396–406. Doi: 10.1111/j.1749-6632.2002.tb02761.x 5 Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364(9447):1789- –1799. Doi: 10.1016/S0140-6736(04)17403-5 6 Fuldeore MJ, Soliman AM. Prevalence and symptomatic burden of diagnosed endometriosis in the United States: national estimates from a cross-sectional survey of 59,411 women. Gynecol Obstet Invest. 2017;82(05):453 –461. Doi: 10.1159/000452660 7 Eisenberg VH, Weil C, Chodick G, Shalev V. Epidemiology of endometriosis: a large population-based database study from a healthcare provider with 2 million members. BJOG. 2018;125 (01):55–62. Doi: 10.1111/1471-0528.14711 8 Owings MF, Kozak LJ. Ambulatory and inpatient procedures in the United States, 1996. Vital Health Stat 13. 1998;(139):1 –119 9 Sinaii N, Plumb K, Cotton L, Lambert A, Kennedy S, Zondervan K, et al. Differences in characteristics among 1,000 women with Rev Bras Ginecol Obstet Vol. 42 No. 10/2020 What the Transcriptome of the Eutopic Endo metrium from Women with Endometriosis Poli-Neto et al.594 endometriosis based on extent of disease. Fertil Steril. 2008;89 (03):538–545. Doi: 10.1016/j.fertnstert.2007.03.069 10 Schliep KC, Mumford SL, Peterson CM, Chen Z, Johnstone EB, Sharp HT, et al. Pain typology and incident endometriosis. Hum Reprod. 2015;30(10):2427 –2438. Doi: 10.1093/humrep/dev147 11 Nnoaham KE, Hummelshoj L, Kennedy SH, Jenkinson C, Zonder- van KT; World Endometriosis Research Foundation Women ’s Health Symptom Survey Consortium. Developing symptom- based predictive models of endometriosis as a clinical screening tool: results from a multicenter study. Fertil Steril. 2012;98(03): 692–701.e5. Doi: 10.1016/j.fertnstert.2012.04.022 12 Surrey E, Carter CM, Soliman AM, Khan S, DiBenedetti DB, Snabes MC. Patient-completed or symptom-based screening tools for endometriosis: a scoping review. Arch Gynecol Obstet. 2017; 296(02):153–165. Doi: 10.1007/s00404-017-4406-9 13 Ballard KD, Seaman HE, de Vries CS, Wright JT. Can symptomatol- ogy help in the diagnosis of endometriosis? Findings from a national case-control study –Part 1. BJOG. 2008;115(11):1382- –1391. Doi: 10.1111/j.1471-0528.2008.01878.x 14 Vercellini P, Fedele L, Aimi G, Pietropaolo G, Consonni D, Cro- signani PG. Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms: a multivariate analysis of over 1000 patients. Hum Reprod. 2007;22 (01):266–271. Doi: 10.1093/humrep/del339 15 Tissot M, Lecointre L, Faller E, Afors K, Akladios C, Audebert A. Clinical presentation of endometriosis identi fied at interval lapa- roscopic tubal sterilization: Prospective series of 465 cases. J Gynecol Obstet Hum Reprod. 2017;46(08):647 –650. Doi: 10.1016/j.jogoh.2017.05.003 16 Hickey M, Ballard K, Farquhar C. Endometriosis. BMJ. 2014;348: g1752. Doi: 10.1136/bmj.g1752 17 Culley L, Law C, Hudson N, Denny E, Mitchell H, Baumgarten M, Raine-Fenning N. The social and psychological impact of endo- metriosis on women ’s lives: a critical narrative review. Hum Reprod Update. 2013;19(06):625 –639. Doi: 10.1093/humupd/ dmt027 18 Nnoaham KE, Hummelshoj L, Webster P, d ’Hooghe T, Nardone FC, Nardone CC, et al; World Endometriosis Research Foundation Global Study of Women ’s Health consortium. Impact of endome- triosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril. 2011;96(02):366 –373.e8. Doi: 10.1016/j.fertnstert.2011.05.090 19 Simoens S, Dunselman G, Dirksen C, Hummelshoj L, Bokor A, Brandes I, et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod. 2012;27(05):1292 –1299. Doi: 10.1093/humrep/ des073 20 Soliman AM, Taylor HS, Bonafede M, Nelson JK, Castelli-Haley J. Incremental direct and indirect cost burden attributed to endo- metriosis surgeries in the United States. Fertil Steril. 2017;107 (05):1181–1190.e2. Doi: 10.1016/j.fertnstert.2017.03.020 21 Zondervan KT, Becker CM, Koga K, Missmer SA, Taylor RN, Viganò P. Endometriosis. Nat Rev Dis Primers. 2018;4(01):9. Doi: 10.1038/s41572-018-0008-5 22 Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244 –1256. Doi: 10.1056/NEJMra1810764 23 Vinatier D, Cosson M, Dufour P. Is endometriosis an endometrial disease? Eur J Obstet Gynecol Reprod Biol. 2000;91(02):113 –125. Doi: 10.1016/s0301-2115(99)00263-8 24 Carvalho L, Podgaec S, Bellodi-Privato M, Falcone T, Abrão MS. Role of eutopic endometrium in pelvic endometriosis. J Minim Invasive Gynecol. 2011;18(04):419–427. Doi: 10.1016/j.jmig.2011.03.009 25 Brosens I, Brosens JJ, Benagiano G. The eutopic endometrium in endometriosis: are the changes of clinical signi ficance? Reprod Biomed Online. 2012;24(05):496 –502. Doi: 10.1016/j. rbmo.2012.01.022 26 Rahmioglu N, Nyholt DR, Morris AP, Missmer SA, Montgomery GW, Zondervan KT. Genetic variants underlying risk of endome- triosis: insights from meta-analysis of eight genome-wide asso- ciation and replication datasets. Hum Reprod Update. 2014;20 (05):702–716. Doi: 10.1093/humupd/dmu015 27 Symons LK, Miller JE, Kay VR, Marks RM, Liblik K, Koti M, Tayade C. The immunopathophysiology of endometriosis. Trends Mol Med. 2018;24(09):748–762 28 Izumi G, Koga K, Takamura M, Makabe T, Satake E, Takeuchi A, et al. Involvement of immune cells in the pathogenesis of endo- metriosis. J Obstet Gynaecol Res. 2018;44(02):191 –198. Doi: 10.1111/jog.13559 29 Vallvé-Juanico J, Houshdaran S, Giudice LC. The endometrial immune environment of women with endometriosis. Hum Reprod Update. 2019;25(05):564 –591. Doi: 10.1093/humupd/ dmz018 30 Suda K, Nakaoka H, Yoshihara K, Ishiguro T, Adachi S, Kase H, et al. Different mutation pro files between epithelium and stroma in endometriosis and normal endometrium. Hum Reprod. 2019;34 (10):1899–1905. Doi: 10.1093/humrep/dez155 31 Cousins FL, O DF, Gargett CE. Endometrial stem/progenitor cells and their role in the pathogenesis of endometriosis. Best Pract Res Clin Obstet Gynaecol. 2018;50:27 –38. Doi: 10.1016/j. bpobgyn.2018.01.011 32 Khan KN, Fujishita A, Hiraki K, Kitajima M, Nakashima M, Fushiki S, Kitawaki J. Bacterial contamination hypothesis: a new concept in endometriosis. Reprod Med Biol. 2018;17(02):125 –133. Doi: 10.1002/rmb2.12083 33 Koninckx PR, Ussia A, Tahlak M, Adamyan L, Wattiez A, Martin DC, Gomel V. Infection as a potential cofactor in the genetic -epigenet- ic pathophysiology of endometriosis: a systematic review. Facts Views Vis ObGyn. 2019;11(03):209 –216 34 Kobayashi H, Higashiura Y, Shigetomi H, Kajihara H. Pathogenesis of endometriosis: the role of initial infection and subsequent sterile in flammation (Review). Mol Med Rep. 2014;9(01):9 –15. Doi: 10.3892/mmr.2013.1755 35 Seaman HE, Ballard KD, Wright JT, de Vries CS. Endometriosis and its coexistence with irritable bowel syndrome and pelvic in flam- matory disease: findings from a national case-control study –Part 2. BJOG. 2008;115(11):1392 –1396. Doi: 10.1111/j.1471- 0528.2008.01879.x 36 Takebayashi A, Kimura F, Kishi Y, Ishida M, Takahashi A, Yama- naka A, et al. The association between endometriosis and chronic endometritis. PLoS One. 2014;9(02):e88354. Doi: 10.1371/jour- nal.pone.0088354 37 Lin WC, Chang CYY, Hsu YA, Chiang JH, Wan L. Increased risk of endometriosis in patients with lower genital tract infection: a nationwide cohort study. Medicine (Baltimore). 2016;95(10): e2773. Doi: 10.1097/MD.0000000000002773 38 Cicinelli E, Trojano G, Mastromauro M, Vimercati A, Marinaccio M, Mitola PC, et al. Higher prevalence of chronic endometritis in women with endometriosis: a possible etiopathogenetic link. Fertil Steril. 2017;108(02):289–295.e1. Doi: 10.1016/j.fertnstert.2017.05.016 39 Tai FW, Chang CY, Chiang JH, Lin WC, Wan L. Association of pelvic inflammatory disease with risk of endometriosis: a nationwide cohort study involving 141,460 individuals. J Clin Med. 2018;7 (11):379. Doi: 10.3390/jcm7110379 40 Khan KN, Kitajima M, Hiraki K, Yamaguchi N, Katamine S, Mat- suyama T, et al. Escherichia coli contamination of menstrual blood and effect of bacterial endotoxin on endometriosis. Fertil Steril. 2010;94(07):2860 –3.e1, 3 41 Khan KN, Fujishita A, Masumoto H, Muto H, Kitajima M, Masuzaki H, et al. Molecular detection of intrauterine microbial coloniza- tion in women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2016;199:69 –75. Doi: 10.1016/j.ejogrb.2016.01.040 42 Leonardi M, Hicks C, El-Assaad F, El-Omar E, Condous G. Endome- triosis and the microbiome: a systematic review. BJOG. 2020;127 (02):239–249. Doi: 10.1111/1471-0528.15916 43 Ata B, Yildiz S, Turkgeldi E, Brocal VP, Dinleyici EC, Moya A, Urman B. The endobiota study: comparison of vaginal, cervical and gut Rev Bras Ginecol Obstet Vol. 42 No. 10/2020 What the Transcriptome of the Eutopic Endometrium from Women with Endometriosis Poli-Neto et al. 595 microbiota between women with stage 3/4 endometriosis and healthy controls. Sci Rep. 2019;9(01):2204. Doi: 10.1038/s41598- 019-39700-6 44 Lowe R, Shirley N, Bleackley M, Dolan S, Shafee T. Transcriptomics technologies. PLOS Comput Biol. 2017;13(05):e1005457. Doi: 10.1371/journal.pcbi.1005457 45 Chen L, Sun F, Yang X, Jin Y, Shi M, Wang L, et al. Correlation between RNA-Seq and microarrays results using TCGA data. Gene. 2017;628:200–204. Doi: 10.1016/j.gene.2017.07.056 46 Talbi S, Hamilton AE, Vo KC, T ulac S, Overgaard MT, Dosiou C, et al. Molecular phenotyping of human endometrium distinguishes men- strual cycle phases and underlying biological processes in normo- ovulatory women. Endocrinology. 2006;147(03):1097–1121 47 Burney RO, Talbi S, Hamilton AE, Vo KC, Nyegaard M, Nezhat CR, et al. Gene expression analysis of endometrium reveals proges- terone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology. 2007;148(08):3814 –3826. Doi: 10.1210/en.2006-1692 48 Hever A, Roth RB, Hevezi P, Marin ME, Acosta JA, Acosta H, et al. Human endometriosis is associated with plasma cells and over- expression of B lymphocyte stimulator. Proc Natl Acad Sci U S A. 2007;104(30):12451–12456. Doi: 10.1073/pnas.0703451104 49 Crispi S, Piccolo MT, D’Avino A, Donizetti A, Viceconte R, Spyrou M, et al. Transcriptional pro filing of endometriosis tissues identi fies genes related to organogenesis defects. J Cell Physiol. 2013;228 (09):1927–1934. Doi: 10.1002/jcp.24358 50 Tamaresis JS, Irwin JC, Gold fien GA, Rabban JT, Burney RO, Nezhat C, et al. Molecular classi fication of endometriosis and disease stage using high-dimensional genomic data. Endocrinology. 2014;155(12):4986–4999. Doi: 10.1210/en.2014-1490 51 Poli-Neto OB, Meola J, Rosa-E-Silva JC, Tiezzi D. Transcriptome meta-analysis reveals differences of immune pro file between eutopic endometrium from stage I-II and III-IV endometriosis independently of hormonal milieu. Sci Rep. 2020;10(01):313. Doi: 10.1038/s41598-019-57207-y 52 Mosser DM, Edwards JP. Exploring the full spectrum of macro- phage activation. Nat Rev Immunol. 2008;8(12):958 –969. Doi: 10.1038/nri2448 53 Benoit M, Desnues B, Mege JL. Macrophage polarization in bacte- rial infections. J Immunol. 2008;181(06):3733 –3739. Doi: 10.4049/jimmunol.181.6.3733 54 Galdiero MR, Garlanda C, Jaillon S, Marone G, Mantovani A. Tumor associated macrophages and neutrophils in tumor pro- gression. J Cell Physiol. 2013;228(07):1404 –1412. Doi: 10.1002/ jcp.24260 55 Ersahin T, Tuncbag N, Cetin-Atalay R. The PI3K/AKT/mTOR inter- active pathway. Mol Biosyst. 2015;11(07):1946 –1954. Doi: 10.1039/c5mb00101c Rev Bras Ginecol Obstet Vol. 42 No. 10/2020 What the Transcriptome of the Eutopic Endo metrium from Women with Endometriosis Poli-Neto et al.596